Skip to main content
Clinical Trials/IRCT20160527028109N4
IRCT20160527028109N4RecruitingPhase 3

The effect of diluted ropivacaine in uterine distending fluid on pain after hysteroscopy surgeries

Iran University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 40 years (—)
Sex
Female

Inclusion Criteria

  • Women candidates for hysteroscopy treatment based on the opinion of a specialist
  • Conscious consent to participate in the study

Exclusion Criteria

  • Existence of pelvic inflammatory disease
  • Having known cervical malignancy, severe uterine bleeding, cervical conization
  • Need for intraoperative surgery due to complications (such as laparotomy due to uterine perforation)
  • Having psychological or neurological disorders that affect pain perception.
  • Allergy to rupivacaine
  • Reluctance to continue cooperation while studying
  • Patients with chronic diseases with pain such as low back pain, etc. who use continuous painkillers.
  • Patients have previously had a tubectomy or have a bilateral obstruction of the tube.
  • Patients with preoperative pelvic pain, dyspareunia, dysmenorrhea, with a vas score of 3 or higher.

Investigators

Similar Trials